User contributions

From WikiPathways

Search for contributions

 Show contributions of new accounts only
 IP Address or username: Namespace: all (Main) Talk User User talk WikiPathways WikiPathways talk Image Image talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk Thread Thread talk Summary Summary talk Pw Old Pw Old Talk Pathway Pathway Talk Wishlist Wishlist Talk Portal Portal Talk

From year (and earlier): From month (and earlier): all January February March April May June July August September October November December

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)

• 07:29, 6 June 2023 Homo sapiens:Amino acid metabolism in triple-negative breast cancer cells‎ (layout updates)
• 14:18, 23 March 2023 Arabidopsis thaliana:2-acetyl-1-pyrroline pathway‎ (fixed some of the publication references) (top)
• 13:39, 23 March 2023 Homo sapiens:Sandbox pathway test‎ (test)
• 13:37, 23 March 2023 WP4933‎ (Discussion edited) (top)
• 13:37, 23 March 2023 N Suggested references to be added (1)‎ (New page: 1) Born to run: control of transcription elongation by RNA polymerase II. Fei Xavier Chen, Edwin R. Smith & Ali Shilatifard. Nature Reviews Molecular Cell Biology volume 19, pages 464–47...) (top)
• 12:56, 23 March 2023 Curationtags-definition.xml‎ (top)
• 12:53, 23 March 2023 Curationtags-definition.xml‎
• 11:11, 23 March 2023 Curationtags-definition.xml‎ (revert back)
• 11:08, 23 March 2023 Curationtags-definition.xml‎
• 11:06, 23 March 2023 Curationtags-definition.xml‎ (fix panccannet qc tag issue)
• 13:46, 10 March 2023 Homo sapiens:Sandbox pathway test‎ (test)
• 13:41, 10 March 2023 Homo sapiens:Sandbox pathway test‎ (test)
• 13:40, 10 March 2023 Homo sapiens:Sandbox pathway test‎ (test)
• 13:33, 16 February 2023 Canis familiaris:Hypertrophy Model‎ (fix complexes) (top)
• 13:29, 16 February 2023 Canis familiaris:Insulin signaling‎ (fix complexes)
• 13:28, 16 February 2023 Canis familiaris:Insulin signaling‎ (fix complexes and unconnected lines)
• 14:21, 13 February 2023 Homo sapiens:Fatty acid and lipoprotein transport in hepatocytes‎ (literature reference information added)
• 07:53, 13 February 2023 Homo sapiens:Sandbox pathway test‎ (Test)
• 12:17, 16 January 2023 Homo sapiens:Evolocumab mechanism to reduce LDL cholesterol‎ (fixed reference title)
• 12:16, 16 January 2023 Homo sapiens:Evolocumab mechanism to reduce LDL cholesterol‎ (added doi)
• 10:12, 11 January 2023 Mus musculus:Deregulation of renin-angiotensin system by SARS-CoV infection‎ (layout) (top)
• 20:27, 7 December 2022 Saccharomyces cerevisiae:TCA cycle‎ (fix publication ref)
• 20:23, 7 December 2022 Homo sapiens:TCA cycle in senescence‎ (fix publication references) (top)
• 13:28, 18 November 2022 Homo sapiens:SARS-CoV-2 and COVID-19 pathway‎ (update virus protein style)
• 13:11, 18 November 2022 Homo sapiens:Physiopathology of endothelial dysfunction in coronavirus disease‎ (Ontology Term : 'COVID-19' added !) (top)
• 12:47, 18 November 2022 Homo sapiens:Host-pathogen interaction of human coronaviruses - autophagy‎ (update virus proteins style) (top)
• 12:50, 27 October 2022 Homo sapiens:Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins‎ (lower case SARS-CoV-2 protein names)
• 12:46, 27 October 2022 Homo sapiens:Type I interferon induction and signaling during SARS-CoV-2 infection‎ (lower case SARS-CoV-2 protein names)
• 12:45, 27 October 2022 Homo sapiens:Hijack of ubiquitination by SARS-CoV-2‎ (lower case SARS-CoV-2 protein names)
• 12:41, 27 October 2022 Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway‎ (fix labels of data nodes)
• 12:32, 27 October 2022 Homo sapiens:SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation‎ (fix identifier of N protein)
• 12:31, 27 October 2022 Homo sapiens:SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation‎ (lower case SARS-CoV-2 protein names)
• 12:29, 27 October 2022 Homo sapiens:Activation of NLRP3 inflammasome by SARS-CoV-2‎ (lower case SARS-CoV-2 protein names)
• 12:36, 4 October 2022 Curationtags-definition.xml‎
• 12:18, 4 October 2022 Curationtags-definition.xml‎
• 13:30, 26 September 2022 Homo sapiens:Immune infiltration in pancreatic cancer‎ (making groups instead of individual nodes)
• 13:12, 26 September 2022 Homo sapiens:Cell interactions of the pancreatic cancer microenvironment‎ (change FAS from metabolite to gene product)
• 13:09, 26 September 2022 Homo sapiens:Cell interactions of the pancreatic cancer microenvironment‎ (Modified title)
• 13:07, 26 September 2022 Homo sapiens:Cell interactions of the pancreatic cancer microenvironment‎ (Modified title)
• 13:07, 26 September 2022 Homo sapiens:Cell interactions of the pancreatic cancer microenvironment‎ (Modified title)
• 07:17, 18 August 2022 Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4‎ (fix special shape)
• 19:12, 8 June 2022 Homo sapiens:Cell cycle‎ (fix unconnected pathway node)
• 19:09, 8 June 2022 Homo sapiens:Cell cycle‎ (removed empty groups)
• 18:32, 25 May 2022 Daphnia magna:Serotonin reuptake inhibitor response‎ (Ontology Term : 'serotonin metabolic pathway' added !)
• 18:29, 25 May 2022 Homo sapiens:Markers of kidney cell lineage‎ (Ontology Term : 'regulatory pathway' added !)
• 09:22, 14 April 2022 Homo sapiens:Metabolic reprogramming in pancreatic cancer‎ (connected lines and legend update)
• 14:29, 21 February 2022 Homo sapiens:SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction‎ (fix Ensembl annotation)
• 14:28, 21 February 2022 Homo sapiens:SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction‎ (Ontology Term : 'oxidative stress response pathway' added !)
• 14:28, 21 February 2022 Homo sapiens:SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction‎ (Ontology Term : 'signaling pathway' added !)
• 14:27, 21 February 2022 Homo sapiens:SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction‎ (Ontology Term : 'COVID-19' added !)

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)